TTK Healthcare receives a balance amount of Rs. 208.39 Cr from BSV Pharma
TTK Healthcare Limited received from BSV Pharma Pvt. Ltd. a sum of Rs. 593.11 crore on 9th May, 2022
TTK Healthcare Limited received from BSV Pharma Pvt. Ltd. a sum of Rs. 593.11 crore on 9th May, 2022
The use of procalcitonin testing for sepsis management is highest in the US
The IPO is a complete OFS by existing shareholder Helix Investment Holdings
GMP-compliant documentation of all manufacturing steps for cell and gene therapies
The two-day event focused on the multi-faceted relationship of clinical research stakeholders and looked at bridging the academic and clinical research gap.
Asia’s premier and USA-patented, ANSSI Wellness for spinal decompression was launched in Pune
Expanded capacity in Nansha, China will support mid-scale manufacturing to ensure a smooth transition between early-phase and large-scale commercial production
New Lexington, Massachusetts facility to provide customer education and collaboration opportunities
Natco Chlorantraniliprole (CTPR) Process does not infringe FMC's Indian Patent 298645.
Subscribe To Our Newsletter & Stay Updated